One company has made the big leap and hired someone for marketing jobs in Tampa.
Entia Biosciences, Inc., has hired Sabrina Jetton to spearhead the Company’s product innovation, communications, and branding initiatives as Director of Marketing.
Jetton has been initially tasked with developing and leading the product innovation and branding strategy for the expanded GROH® hair care and beauty line, which has been designed to work synergistically to supply the powerful nutrients from nature that our bodies genetically need for anti-aging and the health of our hair, skin, and nails. Entia’s first medical food product ErgoD2® Hemo, for the treatment of anemia and diabetes, is currently in clinical trials and has a targeted launch during 2014. Other ErgoD2® medical food products for neurodegenerative and auto-immune diseases are in the development pipeline.
Jetton has been leading the preparations for the upcoming launch of the expanded GROH hair care and beauty line, which will be introduced May 19-20 during the Spring Symposium of Intercoiffure in Hollywood, Florida.
“I have been fortunate to travel around the world and lead a number of significant branding, innovation, and positioning projects during my career, talking with everyday consumers and identifying the trends that have allowed my clients to successfully bring new products to market,” said Sabrina Jetton. “People today have information at their fingertips and are becoming more educated and demanding when it comes to what they put on and in their bodies. This is a major global trend that is driving the health and beauty industries to provide more natural and scientifically validated alternatives to drugs and other chemicals. When I first learned about Entia’s 100% USDA certified organic ingredients, biotechnology platform, and extensive patent portfolio, I knew immediately that I wanted to be a part of their team and help bring these important new products to market.”
“Commercialization of our nutritional technologies in the medical foods and consumer products markets is our number one priority,” said Devin Andres, Chief Operating Officer of Entia Biosciences. “Attracting team members of Sabrina’s caliber is essential to the successful launch and distribution of these products and we welcome her insights, energy and extensive experience in this critically important role.”